Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
immunEyze
- Ownership
- Private
- Development stage
- Other
01
Overview
immunEyze appears to be a small specialty contract research organization focused on ophthalmology, particularly dry eye disease and broader ocular surface disease indications. Public references describe the company as performing preclinical and clinical research for ocular surface disease programs rather than developing a disclosed proprietary therapeutic pipeline. The company is associated in public sources with Michael E. Stern, a dry eye disease expert identified as Principal and Chief Science Officer. Based on available evidence, immunEyze is best characterized as a niche ophthalmology-focused research services company rather than a therapeutics developer.
- Therapeutic areas
- Ophthalmology
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on immunEyze.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on immunEyze.